Navigation Links
Treatment for Prescription Drug Addiction and Painkiller Abuse has Risen Sharply Since Onset of Financial Crisis, Reflecting Uncertainty About Economy
Date:2/9/2011

MALIBU, Calif., Feb. 9, 2011 /PRNewswire/ -- The 2007 onset of the financial crisis that upended the U.S. economy and impacted global markets correlated closely with unprecedented numbers of patients seeking treatment for prescription drug addiction and painkiller abuse, according to leading rehabilitation center Cliffside Malibu. The Cliffside Index, the percentage of patients admitted for treatment related to those medications, rose over 60 percent between 2007 and 2008, and has continued to increase each year.

Beginning in 2007, a growing number of patients began expressing heightened states of uncontrollable anxiety about the economy, reported the physicians and other mental and physical health experts who oversee rigorous protocols of daily therapy sessions at the highly regarded facility.  However, leveling off of patient admissions for abuse of painkillers and prescription drugs at the end of 2010 year may signal that the economy is stabilizing or that this is the U.S. public's perception.

Key Findings from Cliffside Malibu's Review:

  • The increase in the proportion of patients seeking treatment for prescription drug and painkiller addiction unrelated to injury has increased 143% since 2005 (from 21.8% to 52.9%). 

  • The largest yearly increase in proportion of patients seeking treatment for prescription drug and painkiller addiction was 60.1% from 2007 to 2008 (at start of the economic crisis)

  • Xanax is by far the most abused substance among patients admitted for treatment of prescription medication addiction (60% of cases), followed by Klonopin and Oxycontin.

  • Beginning in 2007, increasing numbers of patients cited the country's financial situation as a major cause of elevated anxiety levels.

  • Leveling off of patient admissions for painkillers and other prescription drug abuse suggests the economy may be turning around  

"People recovering from substance addiction at Cliffside are apparently beginning to feel that the economy is showing signs of recovery," said Richard Taite, Chief Executive Officer of Cliffside Malibu.  "I anticipate that in 2011 we will see a reduction in the proportion of admitted patients seeking treatment for dependence on prescription drugs."

Dr. Georgina Smith, Program Director of Cliffside Malibu adds, "In recent years we have noticed a higher percentage of our patients expressing anxiety over the state of the economy, and we have treated a record high number of people addicted to prescription pills, which can be misused to mask feelings of anxiety."

About Cliffside Malibu

Cliffside Malibu is a full-service residential drug abuse, painkiller addiction and alcohol addiction treatment center in the Los Angeles area. At Cliffside, teams of highly trained experts administer individually tailored rehabilitation programs for every type of addiction to patients who place a premium on privacy, safety, and, most importantly, effectiveness.  The drug rehab facility gets its name from its striking location on a hill overlooking the Pacific Ocean.  For more information, visit www.cliffsidemalibu.com or call 800 501 1988.  


'/>"/>
SOURCE Cliffside Malibu
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
2. Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
3. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
4. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
5. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
6. Effective Treatment of Lyme Disease-Related Arthritis Depends on Proper Diagnosis
7. San Antonios Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients
8. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
9. Lakewood-Amedex Inc. Receives Notice of Allowance on Three US Patent Applications Relating to Treatment of Hemolytic Uremic Syndrome
10. Mylans Matrix Obtains License for Promising HIV/AIDS Treatment
11. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016 Allergy Diagnostics Market: ... and tests that are used to determine the ... milk, or drugs etc. in the samples by ... immune system. The report on global allergy diagnostics ... the market. The report consists of an executive ...
(Date:12/8/2016)... Markets has announced the addition of the "Endodontic Supplies - Global Strategic ... , ... for Endodontic Supplies in US$ Thousand. The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , Latin America ... provided for the period 2015 through 2022. Also, a six-year historic analysis is ...
(Date:12/8/2016)... 2016  A Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, ... a doença do refluxo gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of Digestive ... , , ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... become Quality Insights beginning January 1, 2017. The name change aligns the ... to measuring and improving health care quality. , “We are very proud of ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced ... counsel and Eric Hoessel to vice president of sales. , Litsinger joined ...
(Date:12/8/2016)... , ... December 08, 2016 , ... David J. ... global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, ... the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... version gives development continuity to its innovative Unified Instance Manager architecture, meeting ... In addition, this new version optimizes the unattended auto-dialing system without agents, ...
Breaking Medicine News(10 mins):